EW vs RM · P/E 47, rev $1.39B vs P/E 7.5, rev $588.5M
Edwards Lifesciences Corp (EW) versus Regional Management Corp (RM) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Regional Management Corp (RM) is a credit services company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported RM revenue for 2024-12-31 was $588.5M. Net income was $41.2M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. RM currently screens at market cap $339.8M and trailing P/E 7.5.
EW currently screens at market cap $49.91B and trailing P/E 46.9. RM currently screens at market cap $339.8M and trailing P/E 7.5.
Not investment advice. Open the EW and RM stock pages for the full models.
Not investment advice.